https://www.selleckchem.com/products/hs-173.html
A cohort study conducted by Lee, et al published in The Journal of Rheumatology revealed that the hazard of overall cancer was higher in patients aged 41-55 with gout than the control group in Korea (adjusted HR [aHR] 1.224, 95% CI 1.073-1.398).1 Their findings are compatible with 1 study in Korea reporting that the hazard of overall cancer was higher in patients aged ≥ 20 years with gout than the control group (aHR 1.053, 95% CI 1.031-1.077, P less then 0.01).2.Many drugs have been implicated as a cause of vasculitis. Although the overa